Client Portfolio
Founded in 1960, Ferozsons Laboratories Limited is a publicly listed pharmaceutical company in Pakistan, specializing in gastroenterology, hepatology, cardiology, oncology, endocrinology, and maternal-child health, including diabetes care.
Industry Leadership & Global Partnerships
Ferozsons has exclusive agreements with leading international pharmaceutical and medical device companies, including:
- Bagó Group (Argentina) – Co-manufacturing and distribution.
- Gilead Sciences (USA) – Exclusive partner for Hepatitis B, Hepatitis C, and HIV treatments, including authorized generics.
- Boston Scientific (USA) – Exclusive distributor for medical devices in cardiology, gastroenterology, pulmonology, and urology.
- Other Partners: BioGaia (Sweden), Biofreeze (USA), and PanTheryx (USA).
Biotech Leadership – BF Biosciences Limited
In collaboration with Bagó Group, Ferozsons established BF Biosciences Limited, Pakistan’s first CGMP-compliant biotech manufacturing facility, dedicated to producing biological medicines.
Key Areas of Specialization
- Gastroenterology & Hepatology – Treatments for digestive and liver diseases.
- Cardiology – Cardiac care products and medical devices.
- Oncology – Cancer treatment solutions.
- Endocrinology & Diabetes Care – Hormonal and metabolic disorder treatments.
- Maternal & Child Health – Women’s and children’s healthcare solutions.
Medical Device Solutions
Ferozsons distributes Boston Scientific’s advanced medical devices for:
- Cardiology & Electrophysiology
- Endoscopy & Gastroenterology
- Pulmonology & Urology
- Peripheral Interventions
Conclusion
With its strong global partnerships, biotech leadership, and expertise in pharmaceuticals and medical devices, Ferozsons Laboratories continues to be a pioneer in Pakistan’s healthcare industry.
